Snowball logo
logo
ANIP

ANI Pharmaceuticals, Inc

ANIP β€’ NASDAQ
$71.23-$0.76Β  (1.06%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
216.1316.4486.8614.4883.4978.4
COGS
100.6138.8181.5250.2432.7340.2
Gross Profit
115.5177.6305.3364.2450.6638.2
Operating Expenses & Income
Operating Income
(39.79)(35.28)46.970.58481.23150.2
Total Operating Expenses
155.3212.9258.3363.6369.4488
R&D Expenses
11.3722.3234.2944.5851.6649.91
Selling General & Admin Expenses
84.29127.8150.4249.6317.7318.5
Earnings from Continuing Operations
Interest Expense
(11.92)(28.05)(26.94)(17.6)(20.06)(34.97)
Interest Income
------
Income Tax Expense
(13.46)(14.77)1.093(3.69)17.4534.29
Net Income
Net Income
(42.6)(47.9)18.78(18.52)78.34105.8
Supplemental
EBIT
(44.14)(34.61)46.81(4.61)115.9170
EBITDA
3.11625.04106.663.12207.3255.8
In millions of USD, except % and values per 1 share